Your search returned 7 results.

Results
	1.	#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_159 Add to cart (remove)
	2.	The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors: Elboga, Umut Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_160 Add to cart (remove)
	3.	Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_162 Add to cart (remove)
	4.	Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_161 Add to cart (remove)
	5.	124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G Local accession number: 2013_166 Add to cart (remove)
	6.	Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins F, Van Nostrand D, Orquiza M, Wartofsky L Local accession number: 2013_158 Add to cart (remove)
	7.	Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L Local accession number: 2013_165 Add to cart (remove)

Powered by Koha